chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He was achy all over after the first shot when mentioning the arm pain; Gastro issues; I've had close to diarrhea for about 2 weeks now, since the first dose; Headache; Pain at the injections site, pain in his arm; Pain at the injections site, pain in his arm; This is a spontaneous case received from a contactable consumer (patient). A 53-year-old male patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0158), via intramuscular route in left deltoid on 07Apr2021 (age at vaccination 53-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history included overweight and afraid of this possible side effects affecting him even more than COVID-19 infection. Concomitant medications were not reported. On an unspecified date, the patient stated that he had close to diarrhoea for about 2 weeks now, since the first dose. On 07Apr2021, the patient experienced pain at the injection site, pain in the arm that started right away after getting the 1st shot. He could not put weight on the arm or without feeling a little pain. The patient stated that he was achy all over after the first shot when mentioning the arm pain. On 12Apr2021, the patient stated that he experienced the worst headache of his life/ When he got the 1st shot, the Monday after, he experienced the worst headache of his life worse than any hang over/ After the first COVID vaccine he experienced the worst headache of his life: It was so bad it knocked him to knees he took Tylenol and it went away. On an unknown date patient stated that he had gastro issues and stated that he had stool that was not fully formed, not diarrhea and not normal but, runny. It was not formed. He is feeling like he has to go after the second shot on 28Apr2021. It has not subsided yet, it was still kind of going right now. He is not rushing to the bathroom every 5 minutes, but its not comfortable, so its improved since the first time, he was very crampy and his stool was liquidy and now it is more solid, it is slightly improving. The outcome of the event pain, diarrhoea and pain in extremity was unknown. The outcome of the event headache was recovered on 12Apr2021 and for other events outcome was recovering.  No follow-up attempts are needed. No further information was expected..
Case number PHEH2014US019295 is an initial spontaneous report received from a nurse on 19 SEP 2014. This report refers to a 61 year old male patient. His medical history and concomitant medication were not reported. On 18 SEP 2014, he was inadvertently vaccinated with FLUVIRIN 2014/2015 (batch number 1412001) intramuscularly at a dose of 01 ml instead of the recommended 0.5 ml dose. Currently no complain was received from the patient. No adverse event was reported following this maladministration (vaccine overdose).
no additional AE details; expired product administered; This spontaneous report was received from an other reporter and refers to a 14-year-old patient of unknown gender. The patient's concurrent conditons, medical history, concomitant medications, drugs reaction or allergies were not provided.  On 24-JUN-2021, the patient was vaccinated with expired hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (lot # R027576 with expiration date of 23-JUN-2021), 0.5 milliliter for prophylaxis. No additional adverse events were reported (expired product administered, no adverse events). combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: R027576; expirationdate: 23-JUN-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Vice-like headache, shooting pain in neck and upper back, sensitivity to light, exhaustion, tinnitus, low appetite, back pain shifted to sacrum and hamstrings second day, painful to sit, stand, walk, put on socks, difficult to concentrate, unable to work for nearly 2 weeks, still extremely low energy.
About 36 hours after the injection (Sunday 3/9 8:00am), I started getting a headache mostly at the base of my skull.  It got progressively worse and spread to the front of my head too. By that evening (Sunday 3/9) it was throbbing like one of the worst headaches I have had. Monday was so bad that I  called in and didn't work. Tuesday 3/9 was still bad. Finally, Tuesday night is started letting up and was able to sleep. I still have a little headache at the back of my head, 9:00am 3/10.  Also, I couldn't sleep Sunday 3/8 and Monday 3/9 night .  I had a Tylenol 3 prescription and used it.  I was taking  2 at a time and it was not helping much.  Also mixed in some ibuprofen.
At approximately 1607, observes found patient having a syncope episode. The observation team went over to the patient and safely moved the patient to the floor. The patient was placed on 1.5L oxygen via nonrebreather.  The staff paramedic was able arouse the patient with a sternal rub. After arousal the patient did not complain of any difficulty breathing or pain any place. The patient was assisted to chair. The patient was able to answer all orientation questions appropriately at 1612. EMS arrived to the location at 1620. The patient was assisted to the ambulance and care was transferred to EMS.
Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). On 11-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant were reported.  No treatment were reported.
finger surgery; facial tics; pain at the injection site; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SURGERY (finger surgery), TIC (facial tics), VACCINATION SITE PAIN (pain at the injection site) and FATIGUE (fatigue) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced SURGERY (finger surgery), TIC (facial tics), VACCINATION SITE PAIN (pain at the injection site) and FATIGUE (fatigue). On 03-Mar-2021, SURGERY (finger surgery), TIC (facial tics), VACCINATION SITE PAIN (pain at the injection site) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The Action taken with mRNA-1273 (Moderna covid-19 vaccine) was not applicable.  No concomitant medications were reported  Treatment includes Anesthesia for surgery on index finger   This case was linked to MOD-2021-064175 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow up received on 13 MAY 2021 and does not contain any new information
got vaccinated twice got shingles/suspected vaccination failure; got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: got vaccinated twice got shingles/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: got shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK receipt date: 17-MAR-2023 The case was received from the patient interactive digital media. The patient got vaccinated twice with Shingles vaccine and got shingles. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Deafness in the left ear, tinnitus in the right ear. Slight dizziness. Started 28 hours after the injection.
Nursing staff was informed that the patient was having a hard time walking and was not able to speak, just mumble.  Presented with rapid eye movement, lip smacking, equal grips bilaterally although difficulty lifting arms.  When asked about pain, pointed to R forehead.   136/99, 79, 20, 99.6.  Appears uncomfortable and continuous mumbling.  To local hospital via ambulance and admitted.  Presumed CVA
BURNING LEGS; HIVES AND WELTS ON BILATERAL LOWER LEGS; DRY LEGS; ITCHY LEGS; TIREDNESS; HEADACHE; MILD FEVER; BUMPS AND SMALL RED DOTS; This spontaneous report received from a patient concerned a 34 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced bumps and small red dots. On 09-APR-2021, the subject experienced tiredness. On 09-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced mild fever. Laboratory data included: Body temperature (NR: not provided) 99.6. On 10-APR-2021, the subject experienced dry legs. On 10-APR-2021, the subject experienced itchy legs. On 10-APR-2021, the subject experienced hives and welts on bilateral lower legs. On 14-APR-2021, the subject experienced burning legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from itchy legs, and burning legs on 15-APR-2021, tiredness, and headache on 11-APR-2021, and mild fever on 10-APR-2021, was recovering from hives and welts on bilateral lower legs, and bumps and small red dots, and the outcome of dry legs was not reported. This report was non-serious.
Pt experienced nausea, a severe headache & a low grade fever within 24 hrs p/immun. Tx included Tylenol & Advil PRN.
13 people, who were applied the vaccine previously, were corona positive after a week; 13 people, who were applied the vaccine previously, were corona positive after a week; This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for 13 patients. This is 9th of 13 reports.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number and expiration date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that 13 people, who were applied the vaccine previously, were corona positive after a week on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021018407 : same reporter, similar suspect drug and event; different patient.
Pt vaccinated with DTP/OPV experienced crying in a high pitched scream, fell asleep woke up again cried (hi pitch) until 9PM. No fever but treated w/Tylenol.
Vaccine was administered 2/6/13 - mom states child wake up crying 2/7/13 c/o headache, pains in her arms and legs with a temp of 102F. 2/8/13 mom called and stated child fully recovered - no fevers or sx's.
Pt. received flu shot on 8-14-10. Patient came in to the pharmacy on 8-16-10 and had redness and a rash that was warm to touch at site of shot.
I experienced dizziness/light-headiness and immediately had an extreme headache with rashes that turned into hives for the rest of the week (took Benadryl for the nausea, hives, dizziness). Approximately one week later, I experienced heart palpitations and no energy.  I called the Pharmacy back and they suggested that I go the ER. I ended having to say that I had a bladder infection to get an appointment to see my PCP. She examined me and discussed the symptoms that I was experiencing and she provide me with the information in reference to Vsafe and advised me not to take the next dosage because of how many people were having the same symptoms as me. She felt that I had an extreme allergic reaction to the vaccine.
My skin feels like it's chapped on the arms above the elbows, the legs above the knees, and all of my torso (shoulders to leg creases). The feeling is bearable when I'm not moving around or my clothing isn't moving around, and I am able to sleep.  But when I get goosebumps, for example, I want to keep still so I don't further irritate the skin by having my clothes brush up against the goosebumps.  This has been going on for about 5 days.  I had other symptoms -- lethargy, intermittent low grade fever, and loss of appetite -- but they have gone away.  I did have the very common reaction to the shingles vaccine at the time and site of the injection - soreness and redness but that had gone away for the most part by the time these symptoms began.
This patient was at work two days after her vaccine and went to the bathroom. When she did not come back to work after around 20 minutes, she was found unresponsive and an ambulance was called. The patient was declared deceased at the  ER with the cause of death initially as cardiac arrest however a full autopsy was performed and  Coroner's office is awaiting that report at this time. We did not know of the death until we went back this week to complete the second round of vaccinations. Since the death happened in such close proximity to the vaccination date we felt it prudent to report.
Less than 24 hours after injection I am experiencing flu like symptoms including a fever(101,) chills, vomiting, headache, diarrhea, and muscle aches.
17OCT98-18OCT98 pt devel redness, swelling, warmth, pain to rt upper arm; tx w/med;
At first just site soreness but then started leg cramp type pain after about ten days and it has not gone away
having joint pain or inflammation of joints and tendons/  joint pain or pain around the joint, so it might be tendons or ligaments.; having joint pain or inflammation of joints and tendons/  joint pain or pain around the joint, so it might be tendons or ligaments.; having joint pain or inflammation of joints and tendons/  joint pain or pain around the joint, so it might be tendons or ligaments.; This is a spontaneous report from a contactable pharmacist (patient).  A 66-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EM9810), via an unspecified route of administration, administered in Left arm on 05Feb2021 at 10:30 as dose 2, single (at the age of 66 years), for covid-19 immunization. There were no medical history and concomitant medications (Other Products: No, Patient History: No). The patient previously received fist dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EL0140), via an unspecified route of administration, on an unspecified date as dose 1, single for (at the age of 66 years), covid-19 immunization. The patient stated that, on 07Feb2021, she was having joint pain or inflammation of joints and tendons. She said her side effects were joint pain, though she was not sure if it was joint pain or pain around the joint, so it might be tendons or ligaments. She told that the side effects began, though she did not notice it right away, on Sunday night, on like the 7th. She reported that, it was not a lot of pain, more discomfort, but it was in her wrists, elbows, shoulders, and knees. She was not sure if it was her joints also because sometimes pain radiates into her arm. She told that the joint pain had gotten more noticeable yesterday and today, and she had done no treatment for it. She personally felt it was not serious, unless this was something that did not go away, and then that would be serious, depending on what was happening. She said that was the question, since she had never been diagnosed with arthritis and never had these before. No corrective treatment was received for the events. The outcome for the events was not recovered at the time of report.  Follow-up attempts completed. No further information expected.
Initial information received on 14-Jan-2019 regarding an unsolicited valid non-serious case received from a consumer or non healthcare professional by phone. This case involves adult female patient (age not reported) who experienced I received the Sanofi flu vaccine this year, and I still got diagnosed with the flu type A, while she received vaccine INFLUENZA VACCINE (Sanofi flu vaccine). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were not reported. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported. On an unspecified date, the patient developed a non-serious flu type A following the administration of INFLUENZA VACCINE. No Lab data was reported. Final diagnosis was received the Sanofi flu vaccine this year, and I still got diagnosed with the flu type A. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for I received the Sanofi flu vaccine this year, and I still got diagnosed with the flu type A. Documents held by the sender: none.
Herpes Simplex; Caller expressed her frustration; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number: unknown), via an unspecified route of administration on 06Feb2021 as 1ST DOSE, SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had herpes simplex and frustration. Outcome of the events was unknown. The patient was due for her 2nd dose on 27Feb2021.  Follow-up attempts completed. No further information expected.
Rash on right arm. Very itchy. Spread to left arm.; Rash on right arm. Very itchy. Spread to left arm.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 45-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER8737), via an unspecified route of administration, administered in Arm Left on 01Apr2021 15:00 (at the age of 45-year-old) as dose number unknown, single for covid-19 immunisation. Medical history included eosinophilic oesophagitis from an unknown date and unknown if ongoing. Concomitant medications included pantoprazole taken for an unspecified indication, start and stop date were not reported; fluticasone propionate (FLOVENT) taken for an unspecified indication, start and stop date were not reported. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021 04:00, the patient experienced rash on right arm, very itchy, spread to left arm. Clinical course: Rash on right arm. Very itchy. Spread to left arm. Topical steroid (clobetasol) not providing relief. Rash ongoing for 13+ days. Won't go away. Prescribed oral steroid (prednisone): also not working. Therapeutic measures were taken as a result of events included topical: clobetasol; oral: prednisone. The events resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Did not have a reaction to the actual vaccine but did test positive for COVID on 09/22/2021
I received my booster shot on 10/30 (Saturday) at 8:45AM. I had a night fever and chills. I was tired all day Sat, Sun and then on Monday 11/1 the area on my arm where I received my booster shot was sore and then the soreness moved up into the top of my shoulder for a bit. Around 10AM I noticed that the gland in my shoulder collarbone area swelled up and was sore. On 11/2 (Tuesday) the swelling moved into both shoulder collarbone areas (left and right sides of me).  Around 3PM it is now only the left shoulder collarbone area is swelled still but not as bad.  note: I found on site this and noticed that it talked about the same thing I have going on with me.  Swollen lymph nodes in my collarbone area.   I just thought I would send in this so that it could be noted.
swallowing problems and it is hard for him to swallow pills; Headache; Very low fever; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DYSPHAGIA (swallowing problems and it is hard for him to swallow pills), HEADACHE (Headache) and PYREXIA (Very low fever) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient experienced HEADACHE (Headache) and PYREXIA (Very low fever). On an unknown date, the patient experienced DYSPHAGIA (swallowing problems and it is hard for him to swallow pills). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Fever, at an unspecified dose and frequency. At the time of the report, DYSPHAGIA (swallowing problems and it is hard for him to swallow pills), HEADACHE (Headache) and PYREXIA (Very low fever) outcome was unknown.            No concomitant medications were reported.  It was reported that patient experienced some adverse events after receiving the second booster dose of the Moderna Covid 19 vaccine. Patient received this 4th dose on May2022 and 24 hours after, he had a headache and very low fever.  Patient took a Tylenol for the symptom.  Patient has swallowing problems and it is hard for him to swallow pills.